BetterBet™ Anti-PD-L1 Half-Life Extended Antibody (CAT#: AES-0622-ZP1011) Datasheet

PD-L1

Creative Biolabs enhances the binding ability of the anti-PD-L1 antibody to FcRn by modifying the Fc of the antibody, thereby increasing the half-life of the anti- antibody.

Increase the half-life of antibodies

Fc engineering technology

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced PD-L1 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.